Clinical Trials Browser

Alopecia, Anxiety Disorders, Body Weight Changes, Breast Neoplasms, Depression, Fatigue, Lung Neoplasms, Nausea, Pain, Sleep Wake Disorders, Vomiting, Colorectal Neoplasms

NCT05265754 2023-02-24

The Effect of Sujok Therapy on Cancer Symptoms

Phase NA Completed

49 enrolled

Gastrointestinal

Fatigue, Gastrointestinal Neoplasms, Sleep Initiation and Maintenance Disorders, Nausea, Neoplasms, Pain, Vomiting

NCT03674294 2023-02-08

CINV

Phase 3 Completed

248 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Vomiting

NCT04430842 2023-01-18

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Phase 1 Completed

15 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Sleepiness, Mesothelioma, Malignant, Anorexia, Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Headache, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Seizures, Speech Disorders, Stomach Neoplasms, Thymoma, Tongue Neoplasms, Urologic Neoplasms, Vomiting, Colorectal Neoplasms, Cholangiocarcinoma

NCT05666583 2022-12-30

The Effect of Art Therapy on Pain, Emesis, Anxiety and Quality of Life, Breast Cancer

Phase NA Completed

60 enrolled

Breast

Anxiety Disorders, Breast Neoplasms, Pain, Vomiting

NCT00086762 2022-09-01

Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors

Phase NA Completed

474 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Disease, Gastrointestinal Neoplasms, Nausea, Prostatic Neoplasms, Vomiting

NCT03948477 2022-05-25

PantoCIN

Phase 2 Completed

160 enrolled

Breast

Breast Neoplasms, Neoplasms, Vomiting

NCT04232423 2022-01-21

OLN-EME

Phase 3 Completed

90 enrolled

Vomiting

NCT03631004 2022-01-13

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Phase 2/3 Completed

100 enrolled

Nausea, Vomiting, Postoperative Nausea and Vomiting

NCT03143829 2021-12-29

Promoting Cancer Symptom Management in Older Adults

Phase NA Completed

80 enrolled 11 charts

Neoplasms, Vomiting

NCT01363479 2021-09-22

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Phase 3 Completed

743 enrolled 10 charts

Vomiting

NCT01346267 2021-08-18

SCUSF1202

Phase NA Completed

187 enrolled 5 charts

CNS

Astrocytoma, Meningioma, Nausea, Oligodendroglioma, Vomiting, Central Nervous System Neoplasms, Choroid Plexus Neoplasms

NCT03137121 2021-08-17

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

Phase 2/3 Completed

30 enrolled 9 charts

Nausea, Vomiting

NCT02909478 2021-07-29

Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer

Phase 3 Completed

315 enrolled

Gastrointestinal

Vomiting, Colorectal Neoplasms

NCT01536392 2021-06-11

Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation

Phase 3 Completed

76 enrolled 8 charts

Gynecologic

Uterine Cervical Neoplasms, Nausea, Vomiting

NCT01661335 2021-03-23

Efficacy of Aprepitant (Emend®) in Children

Phase 3 Completed

19 enrolled

Nausea, Neoplasms, Vomiting

NCT04651608 2021-03-03

The Effect of Acupressure Chemotherapy-related Nausea Vomiting in Children

Phase NA Completed

44 enrolled

Nausea, Neoplasms, Vomiting

NCT00553059 2020-10-09

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

Phase 3 Completed

62 enrolled 15 charts

Nausea, Vomiting

NCT03572829 2020-07-15

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

Phase 2 Completed

44 enrolled

Head & Neck

Head and Neck Neoplasms, Vomiting

NCT03403712 2020-06-01

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Phase 3 Completed

404 enrolled 19 charts

Vomiting

NCT00003685 2020-04-03

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Phase 3 Completed

230 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms, Nausea, Pain, Vomiting

NCT00016380 2020-04-03

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Phase 3 Completed

211 enrolled

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Nausea, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Seminoma

NCT03313193 2019-10-11

ACT-CC

Phase NA Completed

95 enrolled

Anxiety Disorders, Depression, Fatigue, Nausea, Pain, Vomiting, Neoplasms, Second Primary

Clinical Trials

MANDALACHEMO

NAUVOLA

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

REFYO-R

Geranium Inhalation Aromatherapy for Reducing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy

Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

The Impact of Oral Cryotherapy and Chewing Gum Interventions

The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting

Tiredness and Nausea and Vomiting Management in Oncology Patients

The Effect of Children's Laughter Video on Oncology Patient

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

ProTreat

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

The Effect of Mandala Technique on Acute Nausea-vomiting and Comfort Level in Cancer Patients

NRR

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

CINV

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Efficacy of Ear Acupuncture in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Effectiveness of Laserpuncture and Standard Antiemetic on RINVR Scores in Adolescent Patients Undergoing Chemotherapy

A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting

Peppermint Inhalation Versus Swedish Massage on Chemotherapy Induced-Nausea and Vomiting in Children With Leukemia

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy

Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide

Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer

The Effect of Sujok Therapy on Cancer Symptoms

CINV

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

The Effect of Art Therapy on Pain, Emesis, Anxiety and Quality of Life, Breast Cancer

Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors

PantoCIN

OLN-EME

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Promoting Cancer Symptom Management in Older Adults

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

SCUSF1202

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer

Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation

Efficacy of Aprepitant (Emend®) in Children

The Effect of Acupressure Chemotherapy-related Nausea Vomiting in Children

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

ACT-CC